Beam Therapeutics (BEAM) Other Operating Expenses (2019 - 2025)

Beam Therapeutics (BEAM) has 7 years of Other Operating Expenses data on file, last reported at $384.6 million in Q4 2025.

• On a quarterly basis, Other Operating Expenses rose 411.04% year-over-year to $384.6 million in Q4 2025; TTM through Mar 2026 was $260.0 million, a 209.39% increase from a year earlier, with the FY2024 full-year figure at -$462.2 million, up 8.91% from the prior year.
• Other Operating Expenses for Q4 2025 stood at $384.6 million, up from -$124.5 million in the prior quarter.
• Over the last five years, Other Operating Expenses for BEAM reached as high as $384.6 million in Q4 2025 and fell as low as -$507.4 million in Q4 2023.
• Historically, Other Operating Expenses has averaged -$119.7 million across 5 years, with a median of -$118.9 million in 2024.
• Across the five-year window, Other Operating Expenses sank 38.83% in 2023 and surged 411.04% in 2025, its largest moves.
• Year by year, Other Operating Expenses stood at -$1.2 million in 2021, then tumbled by 30688.63% to -$365.5 million in 2022, then tumbled by 38.83% to -$507.4 million in 2023, then jumped by 75.63% to -$123.6 million in 2024, then jumped by 411.04% to $384.6 million in 2025.
• Per Business Quant data, the three most recent Other Operating Expenses figures were $384.6 million in Q4 2025, -$124.5 million in Q3 2025, and -$123.6 million in Q4 2024.